Reporting owner · Q3 2026 · CIK 2057389

McGrane Ashley: insider trades.

McGrane Ashley reported 15 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($79K), across 1 company.

Transactions
15
Purchases (P)
0
Sales (S)
4
Companies
1
Name as filed
McGrane Ashley

Companies

CompanyRelationshipTransactions
ZoomInfo Technologies Inc. (GTM)Officer · General Counsel and Corp Sec15

Transactions

15 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-02ZoomInfo Technologies Inc.S34$4.17107,037Form 4
2026-09-01ZoomInfo Technologies Inc.F70$4.24107,071Form 4
2026-09-01ZoomInfo Technologies Inc.M207—107,141Form 4
2026-08-07ZoomInfo Technologies Inc.S16,400$4.16106,934Form 4
2026-08-04ZoomInfo Technologies Inc.S997$3.56123,334Form 4
2026-08-01ZoomInfo Technologies Inc.F1,997$3.3124,331Form 4
2026-08-01ZoomInfo Technologies Inc.M5,987—126,328Form 4
2026-07-02ZoomInfo Technologies Inc.S2,461$2.98120,341Form 4
2026-07-01ZoomInfo Technologies Inc.M8,375—94,933Form 4
2026-07-01ZoomInfo Technologies Inc.M781—80,928Form 4
2026-07-01ZoomInfo Technologies Inc.M612—81,540Form 4
2026-07-01ZoomInfo Technologies Inc.M551—82,091Form 4
2026-07-01ZoomInfo Technologies Inc.M4,467—86,558Form 4
2026-07-01ZoomInfo Technologies Inc.F21,349$2.93122,802Form 4
2026-07-01ZoomInfo Technologies Inc.M49,218—144,151Form 4

Questions

What stock did McGrane Ashley buy or sell?

McGrane Ashley reported 15 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($79K), across 1 company.

Is McGrane Ashley the same person as other filers with this name?

This page covers SEC CIK 2057389 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/mcgrane-ashley-2057389.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.